Pellecome™ LLC To Launch New Hormone Pellet Delivery System At The Aesthetic Show 2018

https://www.prnewswire.com/news-releases/pellecome-llc-to-launch-new-hormone-pellet-delivery-system-at-the-aesthetic-show-2018-300676667.html

RANDOLPH, N.J., July 6, 2018 /PRNewswire/ — Pellecome™ LLC launches the Re3™ Advanced Pellet Delivery System for Men & Women. This novel medical device is the vision of founder, Dr. Enrique G. Jacome, a board-certified Ob-Gyn from Rancho Mirage, California who discovered a better way to provide hormone balance to patients other than methods previously available. He created the Re3™ Advanced Pellet Delivery System improving the hormone pellet insertion process – making it easier, safer, and more reliable.

Dr. Jacome’s a specialist in hormone replacement therapy since 1995. In 2002, Dr. Jacome turned his focus to natural hormone replacement therapy, using timed-release Bio-identical Hormone Replacement Therapy (BHRT) pellet implants. Compounded using hormones biologically identical to those created naturally in the body, fused pellet implants are the size of a grain of rice and are inserted under the skin in a simple office procedure.

“After years of using a standard trocar and forceps to perform the insertion procedure, it was obvious to me that the procedure had to be improved to make it more accessible to a wider segment of physicians.  I think the system that I have perfected is the best solution for expanding BHRT to the millions of patients that can benefit from this therapy.” – Dr. Enrique G. Jacome

Pellecome’s CEO, Melissa Vinci-Rainis, “We are so excited to bring Dr. Jacome’s vision to market; the opportunity that this product represents is truly innovative.  It is our dedicated purpose to maximize the penetration of BHRT into as many specialties as possible. There really is no limit to the variety of physicians that can take advantage of this revenue stream in their practice.”

The Re3™ Advanced Pellet Delivery System includes the following:

  • Ergonomically designed INSERTION TOOL with NEEDLE GUIDE
  • Precision SCALPEL
  • Convenient FUNNEL

Pellecome™ LLC is a company of scientists and clinicians established to provide safer, faster and more convenient delivery of BHRT. Pellecome was created with a passion for helping patients achieve a balanced endocrine environment using measured hormone treatments with an improved, simplified method of hormone pellet administration. Streamlining the therapeutic process allows HCPs with various levels of experience to incorporate BHRT into their practices.

To learn more about Pellecome and the advantages of the Re3™ Advanced Pellet Delivery System, go to www.pellecome.com.

SOURCE Pellecome LLC

About This Site

When considering bioidentical hormone replacement therapy, or BHRT, you will find many BHRT options available. Here we look at multiple companies specializing in BHRT and break down each one to learn more about the company, their approach to bioidentical hormones replacement therapy, their treatment options, what makes them different, and the pros and cons of each one.

Bioidentical Hormone Replacement Therapy News

“FDA Warning Letter to EvexiPEL’s Pellet Supplier, Farmakeio

“FDA Warning Letter to EvexiPEL’s Pellet Supplier, Farmakeio

During the inspection, the FDA investigator noted that drug products produced by your facility failed to meet the conditions of section 503B. The evidence collected indicates that your facility’s drug products were not compounded in an outsourcing facility that is in compliance with the requirements of section 503B

read more
Hormone Replacement Therapy Market Analysis By Major Players Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG

Hormone Replacement Therapy Market Analysis By Major Players Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG

The Global Hormone Replacement Therapy Market, by Route of Administration (Parenteral and Oral), by Therapy Type (Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy, and HGH (Human Growth Hormone) Replacement Therapy), by Application (Menopause, Hypothyroidism, Growth Hormone Deficiency, and Male Hypogonadism), by Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and by Region (North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) had a market valuation of US$ 10.58 Billion in 2017, and is estimated to grow at a CAGR of 5.2 percent during the forecast period (2018 – 2026).

read more
How Hypogonadism Is Treated

How Hypogonadism Is Treated

Hypogonadism, a condition in which the body produces insufficient sex hormones, causes a wide range of symptoms that vary based on age and sex at birth.

read more
BodyLogicMD Announces $5,000 Scholastic Scholarship for Medical Students Interested in Pursuing a Career Focused in Achieving Better Patient Care and Outcomes

BodyLogicMD Announces $5,000 Scholastic Scholarship for Medical Students Interested in Pursuing a Career Focused in Achieving Better Patient Care and Outcomes

BodyLogicMD, the most highly-trained network of practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, is offering a $5,000 scholarship per semester to one deserving medical student with aspirations of a career that is centered on optimal health and healing in the field of integrative medicine.

read more